Matches in Wikidata for { <http://www.wikidata.org/entity/Q97890095> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q97890095 description "article scientifique publié en 2020" @default.
- Q97890095 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97890095 description "scientific article published on 25 July 2020" @default.
- Q97890095 description "wetenschappelijk artikel" @default.
- Q97890095 description "наукова стаття, опублікована 25 липня 2020" @default.
- Q97890095 name "RNA-targeted Cu(II)-based potential antitumor drug entity: comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies" @default.
- Q97890095 name "RNA-targeted Cu(II)-based potential antitumor drug entity: comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies" @default.
- Q97890095 type Item @default.
- Q97890095 label "RNA-targeted Cu(II)-based potential antitumor drug entity: comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies" @default.
- Q97890095 label "RNA-targeted Cu(II)-based potential antitumor drug entity: comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies" @default.
- Q97890095 prefLabel "RNA-targeted Cu(II)-based potential antitumor drug entity: comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies" @default.
- Q97890095 prefLabel "RNA-targeted Cu(II)-based potential antitumor drug entity: comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies" @default.
- Q97890095 P1433 Q97890095-2E1E0080-3CEC-4454-9919-9AA268AF9783 @default.
- Q97890095 P1476 Q97890095-D02B2E55-137F-414C-A731-FB985F183931 @default.
- Q97890095 P2093 Q97890095-11A78F13-0FA4-4301-BDCE-CFE2FAAB3B2A @default.
- Q97890095 P2093 Q97890095-38DB72DB-246C-4D97-B10D-E78578E37A98 @default.
- Q97890095 P2093 Q97890095-4AEFF878-4B0A-43CB-8462-19730149EA39 @default.
- Q97890095 P2093 Q97890095-60853CE3-FE02-4D88-9F9C-B3137A504FED @default.
- Q97890095 P304 Q97890095-538F205C-E45E-4EB6-9E3D-A99E42B50FAB @default.
- Q97890095 P31 Q97890095-BFAEB4C5-6895-4334-9AB4-1FDFD775E071 @default.
- Q97890095 P356 Q97890095-25D36DE6-97F9-42F0-AFB6-BC202CFEC396 @default.
- Q97890095 P577 Q97890095-DF66DCA7-46F3-4916-B0D9-E780E7719562 @default.
- Q97890095 P698 Q97890095-A652E755-2677-4D22-9F82-23985D15F211 @default.
- Q97890095 P356 07391102.2020.1797535 @default.
- Q97890095 P698 32715942 @default.
- Q97890095 P1433 Q15754747 @default.
- Q97890095 P1476 "RNA-targeted Cu(II)-based potential antitumor drug entity: comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies" @default.
- Q97890095 P2093 "Farukh Arjmand" @default.
- Q97890095 P2093 "Kaneez Fatima" @default.
- Q97890095 P2093 "Sabiha Parveen" @default.
- Q97890095 P2093 "Siffeen Zehra" @default.
- Q97890095 P304 "1-14" @default.
- Q97890095 P31 Q13442814 @default.
- Q97890095 P356 "10.1080/07391102.2020.1797535" @default.
- Q97890095 P577 "2020-07-25T00:00:00Z" @default.
- Q97890095 P698 "32715942" @default.